NOTICE
ANSM - Updated on : 01/08/2023
Product name
OLIGOSTIM COPPER GOLD SILVER, sublingual tablet
Copper (gluconate) / Gold (powder) / Colloidal silver
Box
Please read this leaflet carefully before taking this medicine, as it contains important information for you.
You must always take this medicine in strict accordance with the information given in this leaflet or by your doctor or pharmacist.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist for advice and information.
- If you experience any undesirable effects, talk to your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. See section 4.
- You should contact your doctor if you do not feel any improvement or if you feel less well.
What does this leaflet contain?
1. What is OLIGOSTIM COPPER OR SILVER sublingual tablet and what is it used for?
2. What do I need to know before taking OLIGOSTIM COPPER OR SILVER sublingual tablet?
3. How is OLIGOSTIM COPPER GOLD sublingual tablet taken?
4. What are the possible side effects?
5. How to store OLIGOSTIM COPPER OR SILVER sublingual tablet?
6. Package contents and other information.
1. WHAT IS OLIGOSTIM COPPER OR SILVER, sublingual tablet AND WHAT IS IT USED FOR?
Pharmacotherapeutic class: OLIGOTHERAPY (V: Miscellaneous)
This drug is used in adults as a ground modifier, particularly during the convalescence phase of infectious diseases and asthenic conditions.
2. WHAT DO I HAVE TO KNOW BEFORE TAKING OLIGOSTIM COPPER OR SILVER, sublingual tablet?
If your doctor has informed you of an intolerance to certain sugars, contact him/her before taking this medicine.
Never take OLIGOSTIM COPPER OR SILVER, sublingual tablet:
- if you are allergic to the active substances or to any of the other components of this medicine, as listed in section 6.
Warnings and precautions
Talk to your doctor or pharmacist before taking OLIGOSTIM COPPER OR SILVER sublingual tablet.
Treatment with this trace mineral does not dispense with any specific treatment.
This medicine is not recommended for patients with galactose intolerance, Lapp lactase deficiency or glucose or galactose malabsorption syndrome (rare hereditary diseases).
Children and adolescents
FOR ADULTS ONLY
Other medicines and OLIGOSTIM COPPER OR SILVER, sublingual tablet
Tell your doctor or pharmacist if you are taking, have recently taken or may take any other medicines.
OLIGOSTIM COPPER GOLD, sublingual tablet with food, drink and alcohol
Not applicable.
Pregnancy, breast-feeding and fertility
As a precautionary measure, this medicine should not be used during pregnancy or while breast-feeding.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to become pregnant, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Not applicable.
OLIGOSTIM COPPER OR SILVER, sublingual tablet contains lactose.
3. HOW TO TAKE OLIGOSTIM COPPER GOLD, sublingual tablet?
Always take this medicine exactly as prescribed by your doctor or pharmacist. Check with your doctor or pharmacist if in doubt.
The recommended dose is 1 to 2 sublingual tablets a day.
Take by mouth.
Allow tablets to melt under the tongue.
Take in the morning on an empty stomach or between meals.
Use in children and adolescents
FOR ADULTS ONLY
If you have taken more OLIGOSTIM COPPER OR SILVER, sublingual tablet than you should have
No cases of overdose have been reported.
If you forget to take OLIGOSTIM COPPER OR SILVER, sublingual tablet
Not applicable.
If you stop taking OLIGOSTIM COPPER GOLD, sublingual tablet
Not applicable.
If you have any further questions about the use of this medicine, please ask your doctor or pharmacist.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Like all medicines, this drug may cause undesirable effects, but they do not occur systematically in everyone.
Reporting side effects
If you experience any side effects, please tell your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. You can also report adverse reactions directly via the national reporting system: Agence nationale de sécurité du médicament et des produits de santé (ANSM) and the network of Regional Pharmacovigilance Centers.
By reporting adverse reactions, you are helping to provide more information on drug safety.
5. HOW TO STORE OLIGOSTIM COPPER OR SILVER, sublingual tablet?
Keep out of sight and reach of children.
Do not use this medicine after the expiration date indicated on the label or outer packaging. The expiration date refers to the last day of that month.
This medicine should be stored at room temperature.
Do not dispose of any medicine down the drain or in the household waste. Ask your pharmacist to identify any medicines you no longer use. This will help protect the environment.
6. CONTENTS AND OTHER INFORMATION
What OLIGOSTIM COPPER OR SILVER, sublingual tablet contains
- The active ingredients are :
Copper gluconate .................................................................................................... 0.220 mg
Quantity corresponding to copper metal.......................................................................... 0.031 mg
Gold powder................................................................................................................. 0.098 mg
Colloidal silver........................................................................................................... 0.070 mg
For one sublingual tablet.
- Other components are : Lactose, croscarmellose A, magnesium stearate.
What is OLIGOSTIM COPPER OR SILVER, sublingual tablet and what does it contain?
This medicine comes in the form of a sublingual tablet; tube of 40 sublingual tablets.
Marketing authorization holder
LABORATOIRE DES GRANIONS
LE PARADOR II
5 ALLEE CROVETTO FRERES
98000 MONACO
Marketing authorization holder
LABORATOIRE DES GRANIONS
LE PARADOR II
5 ALLEE CROVETTO FRERES
98000 MONACO
Manufacturer
LABORATOIRE DES GRANIONS
LE PARADOR II
5 ALLEE CROVETTO FRERES
98000 MONACO
Product names in member states of the European Economic Area
Not applicable.
This leaflet was last revised on :
{month YYYY}.
Other
Detailed information on this drug is available on the ANSM (France) website.